Literature DB >> 28411222

Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms.

Elizabeth J Stewart1, David E Payne2, Tianhui Maria Ma3, J Scott VanEpps4, Blaise R Boles2, John G Younger4, Michael J Solomon1.   

Abstract

The prevalence and structure of Staphylococcus aureus and Staphylococcus epidermidis within multispecies biofilms were found to depend sensitively on physical environment and antibiotic dosage. Although these species commonly infect similar sites, such as orthopedic implants, little is known about their behavior in multispecies communities, particularly in response to treatment. This research establishes that S. aureus is much more prevalent than S. epidermidis when simultaneously seeded and grown under unstressed conditions (pH 7, 37°C) in both laboratory and clinical strains. In multispecies communities, S. epidermidis is capable of growing a more confluent biofilm when the addition of S. aureus is delayed 4 to 6 h during 18 h of growth. Different vancomycin dosages generate various behaviors: S. epidermidis is more prevalent at a dose of 1.0 μg/ml vancomycin, but reduced growth of both species occurs at 1.9 μg/ml vancomycin. This variability is consistent with the different MICs of S. aureus and S. epidermidis Growth at higher temperature (45°C) results in an environment where S. aureus forms porous biofilms. This porosity allows S. epidermidis to colonize more of the surface, resulting in detectable S. epidermidis biomass. Variations in pH result in increased prevalence of S. epidermidis at low pH (pH 5 and 6), while S. aureus remains dominant at high pH (pH 8 and 9). This work establishes the structural variability of multispecies staphylococcal biofilms as they undergo physical and antimicrobial treatments. It provides a basis for understanding the structure of these communities at infection sites and how treatments disrupt their multispecies behaviors.IMPORTANCEStaphylococcus aureus and Staphylococcus epidermidis are two species of bacteria that are commonly responsible for biofilm infections on medical devices. Biofilms are structured communities of bacteria surrounded by polysaccharides, proteins, and DNA; bacteria are more resistant to antimicrobials as part of a biofilm than as individual cells. This work investigates the structure and prevalence of these two organisms when grown together in multispecies biofilms and shows shifts in the behavior of the polymicrobial community when grown in various concentrations of vancomycin (an antibiotic commonly used to treat staphylococcal infections), in a high-temperature environment (a condition previously shown to lead to cell disruption and death), and at low and high pH (a change that has been previously shown to soften the mechanical properties of staphylococcal biofilms). These shifts in community structure demonstrate the effect such treatments may have on multispecies staphylococcal infections.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Staphylococcus aureus; Staphylococcus epidermidis; biofilm structure; multispecies biofilms

Mesh:

Substances:

Year:  2017        PMID: 28411222      PMCID: PMC5452825          DOI: 10.1128/AEM.03483-16

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  46 in total

Review 1.  Biofilm formation as microbial development.

Authors:  G O'Toole; H B Kaplan; R Kolter
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

Review 2.  Biofilms as complex differentiated communities.

Authors:  P Stoodley; K Sauer; D G Davies; J W Costerton
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

3.  Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.

Authors:  F W Goldstein; A Coutrot; A Sieffer; J F Acar
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

4.  Staphylococcus epidermidis biofilms with higher proportions of dormant bacteria induce a lower activation of murine macrophages.

Authors:  Filipe Cerca; Filipa Andrade; Ângela França; Elva Bonifácio Andrade; Adília Ribeiro; Agostinho A Almeida; Nuno Cerca; Gerald Pier; Joana Azeredo; Manuel Vilanova
Journal:  J Med Microbiol       Date:  2011-07-28       Impact factor: 2.472

5.  agr-Dependent interactions of Staphylococcus aureus USA300 with human polymorphonuclear neutrophils.

Authors:  Yun Yun Pang; Jamie Schwartz; Matthew Thoendel; Laynez W Ackermann; Alexander R Horswill; William M Nauseef
Journal:  J Innate Immun       Date:  2010-09-10       Impact factor: 7.349

6.  Management of infection associated with total hip arthroplasty according to a treatment algorithm.

Authors:  S G Giulieri; P Graber; P E Ochsner; W Zimmerli
Journal:  Infection       Date:  2004-08       Impact factor: 3.553

7.  Characterization of a Pseudomonas putida rough variant evolved in a mixed-species biofilm with Acinetobacter sp. strain C6.

Authors:  Susse Kirkelund Hansen; Janus A J Haagensen; Morten Gjermansen; Thomas Martini Jørgensen; Tim Tolker-Nielsen; Søren Molin
Journal:  J Bacteriol       Date:  2007-04-27       Impact factor: 3.490

8.  Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.

Authors:  Richard G Wunderink; Jordi Rello; Sue K Cammarata; Rodney V Croos-Dabrera; Marin H Kollef
Journal:  Chest       Date:  2003-11       Impact factor: 9.410

Review 9.  Heating the patient: a promising approach?

Authors:  J van der Zee
Journal:  Ann Oncol       Date:  2002-08       Impact factor: 32.976

10.  Fluorescent protein spectra.

Authors:  G Patterson; R N Day; D Piston
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

View more
  6 in total

1.  Aptamer-Targeted Drug Delivery for Staphylococcus aureus Biofilm.

Authors:  Pernille Ommen; Line Hansen; Bente K Hansen; Hieu Vu-Quang; Jørgen Kjems; Rikke L Meyer
Journal:  Front Cell Infect Microbiol       Date:  2022-04-29       Impact factor: 6.073

Review 2.  Staphylococcal Biofilms in Atopic Dermatitis.

Authors:  Tammy Gonzalez; Jocelyn M Biagini Myers; Andrew B Herr; Gurjit K Khurana Hershey
Journal:  Curr Allergy Asthma Rep       Date:  2017-10-23       Impact factor: 4.806

3.  Alternative sigma factor B (σB) and catalase enzyme contribute to Staphylococcus epidermidis biofilm's tolerance against physico-chemical disinfection.

Authors:  Charles Ochieng' Olwal; Paul Oyieng' Ang'ienda; Daniel Otieno Ochiel
Journal:  Sci Rep       Date:  2019-03-29       Impact factor: 4.379

4.  Skin and nasal colonization of coagulase-negative staphylococci are associated with atopic dermatitis among South African toddlers.

Authors:  Gillian O N Ndhlovu; Felix S Dube; Rasalika T Moonsamy; Avumile Mankahla; Carol Hlela; Michael E Levin; Nonhlanhla Lunjani; Adebayo O Shittu; Shima M Abdulgader
Journal:  PLoS One       Date:  2022-03-17       Impact factor: 3.240

5.  TiAl6V4 Alloy Surface Modifications and Their Impact on Biofilm Development of S. aureus and S. epidermidis.

Authors:  Astrid H Paulitsch-Fuchs; Lukas Wolrab; Nicole Eck; Nigel P Dyer; Benjamin Bödendorfer; Birgit Lohberger
Journal:  J Funct Biomater       Date:  2021-05-18

6.  Differential Effects of Heated Perfusate on Morphology, Viability, and Dissemination of Staphylococcus epidermidis Biofilms.

Authors:  Joanne K Beckwith; J Scott VanEpps; Michael J Solomon
Journal:  Appl Environ Microbiol       Date:  2020-10-01       Impact factor: 4.792

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.